MedTrace Logo

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

NCT05970120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-05-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the performance and safety of using the investigational catheter.

Conditions

  • Scar-related Atrial Tachycardia
  • Persistent Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Ventricular Tachycardia
  • Premature Ventricular Complex

Interventions

DEVICE

NUVISION NAV Ultrasound Catheter

Participants will be scheduled to have a clinically-indicated ablation procedure using NUVISION NAV ultrasound catheter for management of atrial procedure.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Biosense Webster, Inc Clinical Trial · Biosense Webster, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2024-02-22
Completion
2024-02-22
FDA Device
Yes

Countries

  • Croatia
  • Israel
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970120 on ClinicalTrials.gov